The stock of Genpact Ltd (G) has seen a -3.42% decrease in the past week, with a -14.02% drop in the past month, and a -18.07% decrease in the past quarter. The volatility ratio for the week is 0.41%, and the volatility levels for the past 30 days are at 3.83% for G. The simple moving average for the last 20 days is -2.54% for G’s stock, with a simple moving average of -4.87% for the last 200 days.
Is It Worth Investing in Genpact Ltd (NYSE: G) Right Now?
The price-to-earnings ratio for Genpact Ltd (NYSE: G) is 14.50x, which is above its average ratio. Moreover, the 36-month beta value for G is 0.95. Analysts have varying opinions on the stock, with 4 analysts rating it as a “buy,” 2 as “overweight,” 5 as “hold,” and 0 as “sell.”
The public float for G is 160.17M and currently, short sellers hold a 3.42% of that float. On June 05, 2025, G’s average trading volume was 1.60M shares.
G) stock’s latest price update
The stock of Genpact Ltd (NYSE: G) has decreased by -0.28 when compared to last closing price of 42.74.Despite this, the company has seen a loss of -3.42% in its stock price over the last five trading days. seekingalpha.com reported 2025-05-21 that Genpact is a strong Buy, due to its pivot to Data-Tech-AI, robust digital operations, and disciplined cost management fueling long-term growth. The company’s AI Gigafactory, expanding partner ecosystem, and internal AI-led transformation (Client Zero) are major catalysts driving operational efficiency and revenue growth. Q1 FY25 showed strong financials: 8.3% revenue growth, margin expansion, and healthy cash flows, supporting a DCF-based upside of ~30%.
Analysts’ Opinion of G
Many brokerage firms have already submitted their reports for G stocks, with TD Cowen repeating the rating for G by listing it as a “Buy.” The predicted price for G in the upcoming period, according to TD Cowen is $60 based on the research report published on February 07, 2025 of the current year 2025.
Jefferies, on the other hand, stated in their research note that they expect to see G reach a price target of $55, previously predicting the price at $44. The rating they have provided for G stocks is “Buy” according to the report published on January 21st, 2025.
JP Morgan gave a rating of “Neutral” to G, setting the target price at $40 in the report published on July 17th of the previous year.
G Trading at -8.62% from the 50-Day Moving Average
After a stumble in the market that brought G to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -24.91% of loss for the given period.
#####
#####
Insider Trading
Reports are indicating that there were more than several insider trading activities at G starting from Gangestad Nicholas C, who purchase 2,000 shares at the price of $43.97 back on May 13 ’25. After this action, Gangestad Nicholas C now owns 2,000 shares of Genpact Ltd, valued at $87,940 using the latest closing price.
Kalra Balkrishan, the President and CEO of Genpact Ltd, sale 13,600 shares at $48.89 during a trade that took place back on Mar 13 ’25, which means that Kalra Balkrishan is holding 310,246 shares at $664,904 based on the most recent closing price.
Stock Fundamentals for G
Current profitability levels for the company are sitting at:
- 0.15 for the present operating margin
- 0.35 for the gross margin
The net margin for Genpact Ltd stands at 0.11. The total capital return value is set at 0.18. Equity return is now at value 22.21, with 10.95 for asset returns.
Based on Genpact Ltd (G), the company’s capital structure generated 0.09 points at debt to capital in total, while cash flow to debt ratio is standing at 2.92. The debt to equity ratio resting at 0.1. The interest coverage ratio of the stock is 14.05.
Currently, EBITDA for the company is 843.57 million with net debt to EBITDA at -0.39. When we switch over and look at the enterprise to sales, we see a ratio of 1.47. The receivables turnover for the company is 3.48for trailing twelve months and the total asset turnover is 0.99. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.45.
Conclusion
To wrap up, the performance of Genpact Ltd (G) has been bad in recent times. The stock has received a mixed of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.